Press Release (ePRNews.com) - PLAINFIELD, NJ - Sep 14, 2018 - Science and technology are providing answers that humans have been researching for over the years. This new product is another advance that will benefit the medical field and the human race. The R N A Mitochondrial Recoding is a revolutionary, vaccine-like gene-therapy treatment that would re-encode the RNA of the mitochondria, or “powerhouse” of the body’s cells, to enhance cell energy, extend cell life, and enable the cells to more successfully resist a wide range of infection and disease.
R N A Mitochondrial Recoding represents a revolutionary medical breakthrough in the form of gene therapy specifically, the RNA recoding of the cell’s mitochondria. These rod-shaped organelles, often referred to as the power generators or “engine” of the cell, convert oxygen and nutrients into adenosine triphosphate (ATP), the chemical-energy “currency” of the cell that powers the cell’s metabolic activities. RNA Recoding Mitochondrial can be used as a vaccine, or as an antiviral or antibiotic. When a sick or weakened cell is about to die, it would be “infected” by the RNA Mitochondrial Recoding Vaccine. The new information is encoded inside the cell just like a virus would code and replicate. Then the body would now be wanting to fight the vaccine until its properties let the white blood cells antigens come into play for it to realize that it is helping to strengthen the immune system by teaching the body to accept it like it would accept other vaccines to fight off the disease. According to the inventor when a virus infects a cell, it takes over its cellular machinery for its own purpose, that is creating more copies of the virus. During this process, the viruses create long strings of double-stranded RNA (dsRNA), which is not found in human or other animal cells. As part of their natural defenses against viral infection, human cells have proteins that latch onto dsRNA, setting off a cascade of reactions intended to prevent the virus from replicating itself. This stops viruses from evolving and defeating the currently used anti-viral drugs via a synthetic RNA recoded information thus enabling the cell to live a longer, healthier, more-resilient life, destroying or re-programming viral pathogens and helping the cell to successfully fight diseases in the future.
R N A Mitochondrial Recoding is Patent Pending and was invented by Steven Shaw Nuclear Medicine Technologist of Plainfield, NJ who said, “My goal is to re-program, through advanced RNA encoding techniques, the cells’ mitochondria to effectively “vaccinate” every cell in the body to more effectively fight and eliminate bacterial and viral pathogens; promote greater cell energy and vitality; and extend cell-life far beyond its present, “natural” limits of aging.”
EDITOR’S NOTE: Development of this product is being handled by Invents Company. For more information about licensing or sale, contact the Licensing Department at Invents Company Operations Center, P.O. Box 1682, Murrells Inlet, SC 29576 212-620-2629 www.invents.com
Contact: Jeanne Nelson Media Dept: 10845 (646) 503-4817 Jeanne@invents.com Source :
Business Info : Invents Company